2020 Oregon Ballot Measure 110
2020 Oregon Ballot Measure 110 (Measure 110) was a landmark initiative in the state of Oregon, United States, that aimed to decriminalize the possession of small amounts of all illegal drugs and redirect the state's approach towards drug addiction from a criminal justice model to a health-based model. Approved by voters on November 3, 2020, Measure 110 has significant implications for public health policy, criminal justice reform, and drug policy in Oregon and potentially sets a precedent for other states considering similar reforms.
Background[edit]
The movement towards drug decriminalization in Oregon has its roots in the broader War on Drugs policies initiated in the United States in the 1970s. Critics of the War on Drugs have pointed to its role in the mass incarceration of individuals for drug offenses, disproportionately affecting communities of color, and have argued for a shift towards a more compassionate, health-focused approach to drug addiction. Prior to Measure 110, Oregon had already taken steps in this direction, including the decriminalization of marijuana in 2014.
Provisions[edit]
Measure 110 contains several key provisions aimed at reforming how the state addresses drug possession and addiction:
- Decriminalization of the possession of small amounts of drugs for personal use, including substances such as heroin, methamphetamine, cocaine, and LSD, making such offenses no more than a Class E violation, punishable by a maximum fine of $100.
- Establishment of a drug addiction treatment and recovery program funded by the state's marijuana tax revenue and savings from reduced arrests, incarcerations, and prosecutions related to drug possession.
- Creation of "Addiction Recovery Centers" (ARCs) across the state to provide immediate care for those struggling with drug addiction, including health assessments, intervention plans, and referrals to treatment services.
Impact[edit]
The passage of Measure 110 has led to a significant shift in Oregon's drug policy landscape. Early reports indicate a reduction in drug possession arrests and a redirection of resources towards treatment and recovery services. However, the measure has also faced criticism and challenges, including concerns about the availability and accessibility of treatment services, the potential for increased drug use, and the impact on local communities.
Controversy[edit]
Critics of Measure 110 argue that decriminalization may lead to an increase in drug use and related social issues, such as public drug consumption and petty crime. There are also concerns about the state's capacity to provide adequate addiction treatment services and whether the funding allocated through Measure 110 will be sufficient to meet the demand.
Future Directions[edit]
The implementation of Measure 110 is being closely watched by policymakers, public health experts, and advocates across the United States. Its outcomes may influence future drug policy reforms in other states, particularly those considering similar approaches to drug decriminalization and treatment. Ongoing evaluation and research will be critical in assessing the measure's long-term impact on drug use, public health, and criminal justice outcomes in Oregon.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian